265 related articles for article (PubMed ID: 24405714)
1. Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery.
Wang WT; Zhao YN; Yan JX; Weng MY; Wang Y; Chen YQ; Hong SJ
J Hematol Oncol; 2014 Jan; 7():6. PubMed ID: 24405714
[TBL] [Abstract][Full Text] [Related]
2. Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma.
Chen J; Yao D; Li Y; Chen H; He C; Ding N; Lu Y; Ou T; Zhao S; Li L; Long F
Int J Mol Med; 2013 Sep; 32(3):557-67. PubMed ID: 23799609
[TBL] [Abstract][Full Text] [Related]
3. Serum miR-638 Combined with Squamous Cell Carcinoma-Related Antigen as Potential Screening Biomarkers for Cervical Squamous Cell Carcinoma.
Zheng S; Li R; Liang J; Wen Z; Huang X; Du X; Dong S; Zhu K; Chen X; Liu D; Wu J; Liu Y; Zou X; Wang Y; Li J; Zeng F; Feng L; Yang G; Jing C
Genet Test Mol Biomarkers; 2020 Apr; 24(4):188-194. PubMed ID: 32216635
[No Abstract] [Full Text] [Related]
4. Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma.
Hou B; Ishinaga H; Midorikawa K; Shah SA; Nakamura S; Hiraku Y; Oikawa S; Murata M; Takeuchi K
Cancer Biol Ther; 2015; 16(7):1042-6. PubMed ID: 25950115
[TBL] [Abstract][Full Text] [Related]
5. Circulating miR-15b, miR-34a and miR-218 as promising novel early low-invasive biomarkers of cervical carcinogenesis.
Ocadiz-Delgado R; Lizcano-Meneses S; Trejo-Vazquez JA; Conde-Perezprina JC; Garrido-Palmas F; Alvarez-Rios E; García-Villa E; Ruiz G; Illades-Aguiar B; Leyva-Vázquez MA; García-Carrancá A; Gariglio P
APMIS; 2021 Feb; 129(2):70-79. PubMed ID: 33112434
[TBL] [Abstract][Full Text] [Related]
6. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the microRNA expression profile of cervical squamous cell carcinoma metastases.
Ding H; Wu YL; Wang YX; Zhu FF
Asian Pac J Cancer Prev; 2014; 15(4):1675-9. PubMed ID: 24641388
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma.
Wu C; Wang C; Guan X; Liu Y; Li D; Zhou X; Zhang Y; Chen X; Wang J; Zen K; Zhang CY; Zhang C
PLoS One; 2014; 9(3):e92292. PubMed ID: 24651474
[TBL] [Abstract][Full Text] [Related]
9. Identification of autophagy-associated miRNA signature for the cervical squamous cell cancer and high-grade cervical intraepithelial lesions.
Bayramoglu Tepe N; Bozgeyik E; Bozdag Z; Balat O; Ozcan HC; Ugur MG
Reprod Biol; 2021 Sep; 21(3):100536. PubMed ID: 34298410
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
11. Plasma miR-324-3p and miR-1285 as diagnostic and prognostic biomarkers for early stage lung squamous cell carcinoma.
Gao X; Wang Y; Zhao H; Wei F; Zhang X; Su Y; Wang C; Li H; Ren X
Oncotarget; 2016 Sep; 7(37):59664-59675. PubMed ID: 27517633
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma.
Ayaz L; Görür A; Yaroğlu HY; Ozcan C; Tamer L
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1499-506. PubMed ID: 23817697
[TBL] [Abstract][Full Text] [Related]
13. A novel saliva-based microRNA biomarker panel to detect head and neck cancers.
Salazar C; Nagadia R; Pandit P; Cooper-White J; Banerjee N; Dimitrova N; Coman WB; Punyadeera C
Cell Oncol (Dordr); 2014 Oct; 37(5):331-8. PubMed ID: 25156495
[TBL] [Abstract][Full Text] [Related]
14. HPV16
Pulati N; Zhang Z; Gulimilamu A; Qi X; Yang J
J Gene Med; 2019 Nov; 21(11):e3126. PubMed ID: 31498525
[TBL] [Abstract][Full Text] [Related]
15. Prediction of a miRNA-mRNA functional synergistic network for cervical squamous cell carcinoma.
Sun D; Han L; Cao R; Wang H; Jiang J; Deng Y; Yu X
FEBS Open Bio; 2019 Dec; 9(12):2080-2092. PubMed ID: 31642613
[TBL] [Abstract][Full Text] [Related]
16. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma.
Yamamoto N; Kinoshita T; Nohata N; Itesako T; Yoshino H; Enokida H; Nakagawa M; Shozu M; Seki N
Int J Oncol; 2013 May; 42(5):1523-32. PubMed ID: 23483249
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the microRNA profile in early-stage cervical squamous cell carcinoma by next-generation sequencing.
Lin W; Feng M; Chen G; Zhou Z; Li J; Ye Y
Oncol Rep; 2017 Mar; 37(3):1477-1486. PubMed ID: 28098890
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood circulating microRNA-4636/-143 for the prognosis of cervical cancer.
Yin S; Yang M; Li X; Zhang K; Tian J; Luo C; Bai R; Lu Y; Wang M
J Cell Biochem; 2020 Jan; 121(1):596-608. PubMed ID: 31407404
[TBL] [Abstract][Full Text] [Related]
20. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
